The greener prescription: Life cycle environmental impact of oral and IV penicillin treatments

Antibiotics are vital in treating bacterial infections and often administered intravenously (IV) to patients admitted to hospitals. Oral alternatives are generally as effective when used clinically appropriately, but the environmental impact of different dosage forms remain understudied. As healthcare’s environmental impact continue to increase, understanding the impact of treatment choices is essential for promoting sustainable healthcare. We conducted an attributional Life Cycle Assessment (LCA) estimating the environmental impact of penicillin treatment for pneumonia, comparing the impact via IV and oral routes, using both Midpoint and Endpoint indicators using ReCiPe 2016. The analysis included manufacturing, packaging, administration, and disposal phases. Oral treatment had 4–14% of the environmental impact of IV treatment across the impact categories. For IV treatment, the majority of emissions stemmed from IV equipment. Sensitivity analyses showed manufacturing emissions were primarily energy-driven. The environmental impact of oral treatment was influenced by the electricity mix in the country of manufacturing, while the impact of IV treatment could be reduced by up to 38% by implementing equipment recycling. Applying toxicity characterization factors for penicillin excreted to the environment, showed potential underestimation of the Freshwater/Marine Ecotoxicity Potential with an increase of over 8700% and 676%, respectively. Our results indicate prescribing oral formulations when clinically appropriate offers an opportunity to decrease the environmental impact. Reductions could be obtained by sourcing products from regions with low-emission electricity mix and improving waste management of IV equipment by recycling. The continued progress in pharmaceutical LCAs relies on better data availability and harmonized methods. • Comparative life cycle assessment of oral and intravenous penicillin treatments. • System boundary defined as cradle-to-grave. • Functional unit defined as 1 million International Units of penicillin. • Noticeably lower environmental impact for oral penicillin treatment. • Recommendations for future research and future treatment choice for clinical practice.

Authors

Institutions

Publication Details

Journal
Sustainable Chemistry and Pharmacy
Published
2026-02-14
DOI
https://doi.org/10.1016/j.scp.2026.102346
Primary Topic
Climate Change and Health Impacts
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The greener prescription: Life cycle environmental impact of oral and IV penicillin treatments

Sidsel Arnspang Pedersen, Styrmir Gislason, Ciprian Cimpan, Rune Winther Fabrin Olsen et al.
Sustainable Chemistry and Pharmacy
Climate Change and Health Impacts
article

The greener prescription: Life cycle environmental impact of oral and IV penicillin treatments

Sidsel Arnspang Pedersen, Styrmir Gislason, Ciprian Cimpan, Rune Winther Fabrin Olsen, Fahamida Ayivee, Katrine Bitsch Johansen
article en

Abstract

Antibiotics are vital in treating bacterial infections and often administered intravenously (IV) to patients admitted to hospitals. Oral alternatives are generally as effective when used clinically appropriately, but the environmental impact of different dosage forms remain understudied. As healthcare’s environmental impact continue to increase, understanding the impact of treatment choices is essential for promoting sustainable healthcare. We conducted an attributional Life Cycle Assessment (LCA) estimating the environmental impact of penicillin treatment for pneumonia, comparing the impact via IV and oral routes, using both Midpoint and Endpoint indicators using ReCiPe 2016. The analysis included manufacturing, packaging, administration, and disposal phases. Oral treatment had 4–14% of the environmental impact of IV treatment across the impact categories. For IV treatment, the majority of emissions stemmed from IV equipment. Sensitivity analyses showed manufacturing emissions were primarily energy-driven. The environmental impact of oral treatment was influenced by the electricity mix in the country of manufacturing, while the impact of IV treatment could be reduced by up to 38% by implementing equipment recycling. Applying toxicity characterization factors for penicillin excreted to the environment, showed potential underestimation of the Freshwater/Marine Ecotoxicity Potential with an increase of over 8700% and 676%, respectively. Our results indicate prescribing oral formulations when clinically appropriate offers an opportunity to decrease the environmental impact. Reductions could be obtained by sourcing products from regions with low-emission electricity mix and improving waste management of IV equipment by recycling. The continued progress in pharmaceutical LCAs relies on better data availability and harmonized methods. • Comparative life cycle assessment of oral and intravenous penicillin treatments. • System boundary defined as cradle-to-grave. • Functional unit defined as 1 million International Units of penicillin. • Noticeably lower environmental impact for oral penicillin treatment. • Recommendations for future research and future treatment choice for clinical practice.

Sustainable Chemistry and PharmacyVol. 50
University of Southern Denmark (DK), Odense University Hospital (DK), Life Cycle Engineering (United States) (US)
Responsible consumption and production
Openalex Percentile: Top 58%
Climate Change and Health Impacts
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.